Article
A stemness screen reveals C3orf54/INKA1 as a promoter of human leukemia stem cell latency
22 Feb 2019
Abstract excerpt
Abstract There is a growing body of evidence that the molecular properties of leukemia stem cells (LSCs) are associated with clinical outcomes in acute myeloid leukemia (AML), and LSCs have been linked to therapy failure and relapse. Thus, a better understanding of the molecular mechanisms that contribute to the persistence and regenerative potential of LSCs is expected to result in the development of more...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
